A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes
Ontology highlight
SUBMITTER: Slingluff C
PROVIDER: S-EPMC4288705 | biostudies-literature | 2014 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA